Table 1 Mean scores (± standard deviation) for demographic and clinical variables between groups, tested by chi-square or ANOVA
Stage 1b (n = 94) | Stage 2/3 (n = 100) | Controls (n = 50) | Significance Test [p] | Post hoc | |||
|---|---|---|---|---|---|---|---|
1b v 2/3 | 1b v Ctrl | 2/3 v Ctrl | |||||
Females, n (%) | 58 (62%) | 43 (43%) | 29 (58%) | χ2 (2, 244) = 7.4 [.025] | |||
Age, years | 22.2 ± 3.2 | 23.0 ± 3.3 | 23.0 ± 2.7 | F (2, 243) = 2.2 [.118] | |||
Age of onset, years | 15.4 ± 3.3 | 17.6 ± 4.9 | n/a | F (1, 160.8) = 12.7 [.000] | |||
Predicted IQ | 103.0 ± 8.5 | 103.2 ± 10.8 | 106.0 ± 7.8 | F (2, 242) = 1.9 [.148] | |||
Education, years | 12.8 ± 2.1 | 13.1 ± 2.4 | 14.8 ± 2.2 | F (2, 243) = 13.7 [.000] | *** | *** | |
SOFAS | 61.4 ± 11.3 | 56.4 ± 12.5 | 92.0 ± 3.2 | F (2, 143.9) = 557.5 [.000] | ** | *** | *** |
HDRS total | 12.9 ± 6.5 | 12.5 ± 8.5 | 2.0 ± 2.2 | F (2, 150.2) = 149.6 [.000] | *** | *** | |
BPRS total | 40.5 ± 9.6 | 42.7 ± 12.3 | 26.5 ± 2.7 | F (2, 147.4) = 146.2 [.000] | *** | *** | |
K10 total | 28.1 ± 7.7 | 26.0 ± 9.1 | 15.4 ± 5.1 | F (2, 135.5) = 72.4 [.000] | *** | *** | |